A 35-year-old man with asthma presents with acute exacerbation. His baseline FEV₁ is 70% predicted. On examination, he has audible wheeze bilaterally and uses accessory muscles. Pulse oximetry shows SpO₂ 88% on room air. Which feature best distinguishes acute severe asthma exacerbation from acute life-threatening asthma exacerbation?

Explanation

## Acute Asthma Exacerbation Severity: Severe vs Life-Threatening **Key Point:** The feature that **best distinguishes** acute severe from acute life-threatening asthma is the **Peak Expiratory Flow (PEF)**: 40–60% predicted in severe exacerbation vs <40% predicted in life-threatening exacerbation (British Thoracic Society / GINA guidelines). ### Severity Classification & Discriminating Features | Feature | Mild–Moderate | Acute Severe | **Acute Life-Threatening** | |---|---|---|---| | **Dyspnea** | Full sentences | Phrases | Single words / unable to speak | | **Accessory muscle use** | Absent/mild | Present | Present (marked); paradoxical breathing | | **Wheeze** | Audible | Audible | **Silent chest** (no wheeze/breath sounds) | | **Peak flow (% predicted)** | >60% | **40–60%** | **<40%** | | **FEV₁ (% predicted)** | >50% | 25–50% | <25% | | **SpO₂ (room air)** | >90% | 90–95% | <90% | | **PaCO₂** | Normal | Normal or ↓ | **Elevated (>45 mmHg)** — fatigue/impending failure | | **Pulse** | <100 bpm | 100–120 bpm | >120 bpm; pulsus paradoxus possible | ### Why PEF is the Best Discriminator Here **High-Yield:** The question asks which feature **best distinguishes** the two categories. PEF (or FEV₁) provides a **quantitative, objective threshold** that directly separates severe (40–60% predicted) from life-threatening (<40% predicted) exacerbations per BTS/SIGN and GINA guidelines. This is the primary objective criterion used in clinical protocols to escalate management. **Clinical Pearl:** Silent chest (Option A) is indeed a feature of **life-threatening** asthma, but it is a sign *within* the life-threatening category — it does not serve as a comparative discriminator between the two severity levels in the way PEF thresholds do. Silent chest indicates near-complete airflow obstruction and impending respiratory arrest, but PEF cutoffs are the defining classification criteria. ### Why the Other Options Are Incorrect - **Option A (Silent chest):** Silent chest is a feature of life-threatening asthma, not a feature that "distinguishes" severe from life-threatening — it is absent in severe but present in life-threatening. However, the question asks for the feature that **best** distinguishes the two, and PEF provides the most objective, guideline-defined threshold for this distinction. - **Option C (Accessory muscles in severe but not life-threatening):** Factually incorrect — accessory muscle use is present in **both** severe and life-threatening exacerbations (and may be more marked in life-threatening). - **Option D (Tachycardia >120 bpm in severe only):** Factually incorrect — tachycardia >120 bpm is a feature of **life-threatening** exacerbation, not severe alone. ### Pathophysiology of Airflow Obstruction 1. **Severe exacerbation:** Significant but incomplete airway obstruction → PEF 40–60% → wheeze still audible, accessory muscles recruited 2. **Life-threatening exacerbation:** Near-complete obstruction → PEF <40% → minimal air movement → silent chest, hypercapnia, altered consciousness **Reference:** BTS/SIGN British Guideline on the Management of Asthma (2019); GINA Global Strategy for Asthma Management and Prevention (2023). **Mnemonic:** **PEF 40–60% = Severe; PEF <40% = Life-Threatening** — the objective cutoff is the defining discriminator between these two severity categories.